As patients with LOEU prior to development of MCI/dementia inconsistently demonstrate positive tau biomarkers, but frequently show positive amyloid biomarkers, an additional classification category is needed for patients with positive amyloid but with negative tau markers. This evidence concerns the gene MAPT and dementia.